Seller record · Telehealth service

Medi-Weightloss

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: The tirzepatide page, headed as a page about compounded tirzepatide, answers that tirzepatide is FDA-approved for chronic weight management. The footer of every page says compounded drug products are not approved or evaluated by the FDA, but the product page itself states approval. 1 more criterion also fails; see the table below.

At a glance

Medi-WeightlossTelehealth service

6/8criteria passed

Price: Compounded semaglutide $99 for the first month and compounded tirzepatide $199 for the first month, no later price printed
Sells: Wegovy, Zepbound, Saxenda, and 6 more
FDA letters: None on file

Visit Medi-Weightloss See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A national franchise of in-person, physician-supervised weight loss clinics that prescribes Wegovy, Zepbound, Saxenda, compounded semaglutide and tirzepatide and appetite suppressants inside a weekly-visit program, billed to insurance or as a self-pay membership. It names eight compounding pharmacies.

Operating entity Medi-Weightloss Franchising USA, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Medi-Weightloss' pricing page; Medi-Weightloss' tirzepatide page
S2	Prescription gating	PASS	Medi-Weightloss' pricing page; Medi-Weightloss' website
S3	Pharmacy identification	PASS	Medi-Weightloss' FAQ
S4	Compounding disclosure	FAIL	Medi-Weightloss' tirzepatide page; Medi-Weightloss' website
S5	Analytical documentation	FAIL	Medi-Weightloss' semaglutide page; Medi-Weightloss' pricing page; Medi-Weightloss' FAQ
S6	Business address	PASS	Medi-Weightloss' weight loss clinic page; Medi-Weightloss' terms of use page
S7	Price disclosure	PASS	Medi-Weightloss' pricing page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSPrescription medications, including GLP-1 treatments, are available only after medical evaluation and approval by a licensed provider, and the program begins with a new patient visit that includes a medical assessment, lab work and a GLP-1 eligibility review.Source: Medi-Weightloss' pricing page; Medi-Weightloss' tirzepatide page.

S2PASSThe first step is a free assessment, followed by a new patient visit at a clinic that includes the medical assessment, lab work and GLP-1 eligibility review, and medication is available only after a licensed provider approves it. The visit fee pays for that evaluation.Source: Medi-Weightloss' pricing page; Medi-Weightloss' website.

S3PASSThe answers list the pharmacies used for compounded weight loss prescriptions, with addresses: BPI Labs in Largo, Florida, Innovation Compounding in Kennesaw, Georgia, EverWell Pharmacy in Pensacola, Florida, Nova Specialty Pharmacy in Mansfield and Katy, Texas, Absolute Pharmacy in Lutz, Florida, Belmar Pharma Solutions in Odessa, Florida, AnazaoHealth in Tampa, Florida and Empower Pharmacy in Houston, Texas.Source: Medi-Weightloss' FAQ.

S4FAILThe tirzepatide page, headed as a page about compounded tirzepatide, answers that tirzepatide is FDA-approved for chronic weight management. The footer of every page says compounded drug products are not approved or evaluated by the FDA, but the product page itself states approval.Source: Medi-Weightloss' tirzepatide page; Medi-Weightloss' website.

S5FAILNo certificate of analysis or lot document is published on the medication pages, the pricing page, the answers or the terms.Source: Medi-Weightloss' semaglutide page; Medi-Weightloss' pricing page; Medi-Weightloss' FAQ.

S6PASSThe locations page lists a street address and phone number for each clinic, among them 3202 W. Kennedy Blvd., Tampa, FL 33609. The terms say the clinics are independently owned franchises and name Florida law.Source: Medi-Weightloss' weight loss clinic page; Medi-Weightloss' terms of use page.

S7PASSCompounded semaglutide from $99 for the first month and compounded tirzepatide from $199 for the first month, at the same price across doses, after a $199 new patient visit that includes the assessment and lab work. No later monthly price is printed, and the self-pay membership fee is said to vary by program and location. With insurance, most patients pay $0 to $50 a visit.Source: Medi-Weightloss' pricing page.

S8PASSNo FDA warning letter names Medi-Weightloss or Medi-Weightloss Franchising USA, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: Wegovy, Zepbound, Saxenda, compounded semaglutide, compounded tirzepatide, phentermine, phendimetrazine, hormone optimization, vitamin and nutrition injections.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells liraglutide

Visit Medi-Weightloss

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.